Metraipolis › archive › dc_4d35bcc69b70

Cost-effectiveness of switching to S-1 after fluoropyrimidine-induced hand-foot syndrome or cardiovascular toxicity in the treatment of metastatic colorectal… — Europe PMC PMID:41850039

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41850039
DOI
10.1016/j.esmoop.2026.106304
License (as archived)
solo-consultazione
Archived
2026-11-04T08:58:43.759Z
SHA-256 of the archived text
7fd2c3cae1d45319ef96a367d024d33d49ec9b40b63d2d6adbb28d9d3950d07d
Stable URL of this page
https://metraipolis.com/documento/dc_4d35bcc69b70

How to cite

Cost-effectiveness of switching to S-1 after fluoropyrimidine-induced hand-foot syndrome or cardiovascular toxicity in the treatment of metastatic colorectal… — Europe PMC PMID:41850039 — Europe PMC (en), https://europepmc.org/article/MED/41850039 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4d35bcc69b70 (Metraipolis archive dc_4d35bcc69b70, sha256 7fd2c3cae1d45319ef96a367d024d33d49ec9b40b63d2d6adbb28d9d3950d07d)
BibTeX
@misc{dc4d35bcc69b70,
  title = {Cost-effectiveness of switching to S-1 after fluoropyrimidine-induced hand-foot syndrome or cardiovascular toxicity in the treatment of metastatic colorectal… — Europe PMC PMID:41850039},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41850039},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4d35bcc69b70; sha256 7fd2c3cae1d45319ef96a367d024d33d49ec9b40b63d2d6adbb28d9d3950d07d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41850039. Agents can read the archived copy with the MCP tool read_document.